Maria Sirenko
@MariaSirenko
Postdoc in Aifantis and Beck Labs @nyulangone | PhD @GSKGradSchool @MSKCancerCenter @PapaemmanuilLab | population and single cell genomics in heme malignancies
Thrilled to see our work out today! It’s been a joy to be a part of this incredible team! 🧬🩸
🎉Excited to present our latest work out today @Nature 1.What gives a leukemia its phenotype – the oncogenic driver or the differentiation stage of the cell-of-origin? 2.Why do RAS mutations always happen late in AML? 3.Who will relapse after VEN? nature.com/articles/s4158…
🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in @NatureGenet 🧬! shorturl.at/94s5S We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n 🧵👇
Excited to share with all our latest work on the use of single cell tools in following IDH mutant AML patients during their treatment! Out today @CellStemCell !! An amazing collaboration with @AkEisfeld & @PapaemmanuilLab & @landau_lab !!! Driven by the impressive @MariaSirenko…
Time for our own @MariaSirenko to present her work at #myeloidmalignancies25 !! Paper out very soon…@Fusion_Conf
Had a wonderful weekend in Stockholm seeing colleagues at Karolinska. Thanks for the opportunity to present our work and for your hospitality. Now in Crete for a 4-day "layover" at #MyeloidMalignancies25... Looking forward to connecting with everyone here!
Thank you to the @MDSFoundation for the invitation to speak about UBA1 mutations in MDS! An excellent meeting so far #MDS25
we need UBA1 in our myeloid panels .. pls Beautifully delivered presentation by @MariaSirenko 👏🏼#MDS25 @MDSFoundation #MDSsm @Elsa2Bernard @PapaemmanuilLab